A patient with Parkinson's disease is prescribed a selective MAO-B inhibitor as adjunctive therapy. The selectivity for MAO-B at low doses is therapeutically useful because MAO-B preferentially metabolises which substrate?
Choose one answer
Questions and lessons can't be printed or saved as a PDF.
MRCPsych · Paper A
Log inPick your answer. Then see why.
A patient with Parkinson's disease is prescribed a selective MAO-B inhibitor as adjunctive therapy. The selectivity for MAO-B at low doses is therapeutically useful because MAO-B preferentially metabolises which substrate?
Choose one answer